PKC inhibitor
Protein kinase C (PKC) inhibitors are compounds designed to block or modulate the activity of PKC enzymes, a family of serine/threonine kinases crucial for regulating various cellular processes such as cell growth, differentiation, and survival. PKCs are involved in signal transduction pathways activated by hormones, neurotransmitters, and growth factors. Dysregulation of PKC activity has been implicated in numerous diseases, including cancer, neurological disorders, and cardiovascular diseases. PKC inhibitors can act through different mechanisms, including competitive inhibition of ATP binding to the kinase domain, allosteric modulation, interference with substrate binding, or disruption of protein-protein interactions necessary for PKC activation.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:6 Page 1 of 1 1
![3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione](http://file1.lookchem.com/300w/2010-10/805e0cfe-b905-414a-b369-140243178535.png)